TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06092944

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Catheterization
Description: Before the operation,the patient was placed in the left lateral position.The catheter（soft tip epidural catheter 20-gauge-100 cm） was placed at the rhomboid-intercostal plane under ultrasound guidance at the T5-T6 level, followed by ultrasound-guided catheter placed in the anterior serrated muscle plane at the T7-9 level。

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single nerve block
Description: Before the operation,40milliliters of 0.3% ropivacaine was injected into the rhomboid-intercostal fascia plane and anterior serrated muscle plane respectively under the guidance of ultrasound.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single nerve block
Description: Before the operation,40milliliters of 0.3% ropivacaine was injected into the rhomboid-intercostal fascia plane and anterior serrated muscle plane respectively under the guidance of ultrasound.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Continuous nerve block
Description: After surgery,local anesthetics were injected continuously through catheters.Local anesthetic formula:Ropivacaine 300mg + normal saline, prepared into 150milliliters liquid, background dose 2milliliters/h.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PCIA
Description: After surgery, the patient was given controlled intravenous analgesia. Analgesic pump drug formula:Sufentanil 50ug+ Dezocine 20mg+ Granisetron 10mg+150milliliters saline, continuous dose of 2milliliters/h intravenous pump, single injection dose of 2milliliters, locking time of 20 min

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PCIA
Description: After surgery, the patient was given controlled intravenous analgesia. Analgesic pump drug formula:Sufentanil 50ug+ Dezocine 20mg+ Granisetron 10mg+150milliliters saline, continuous dose of 2milliliters/h intravenous pump, single injection dose of 2milliliters, locking time of 20 min

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PCIA
Description: After surgery, the patient was given controlled intravenous analgesia. Analgesic pump drug formula:Sufentanil 50ug+ Dezocine 20mg+ Granisetron 10mg+150milliliters saline, continuous dose of 2milliliters/h intravenous pump, single injection dose of 2milliliters, locking time of 20 min
Study: NCT05212545

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: maltodextrin taken daily for 4 weeks with water

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Prebiotic supplement
Description: Prebiotic supplement taken daily for 4 weeks with water

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Prebiotic combination
Description: prebiotic oligosaccharides mixture taken daily for 4 weeks with water

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Prebiotic oligosaccharides
Description: Prebiotic oligosaccharides taken daily for 4 weeks with water
Study: NCT03760497

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Restorative treatment
Description: For all groups, first the patients will be submitted to the anesthetic technique indicated with Lidocaine + Epinephrine 1: 100,000 (New DFL, Rio de Janeiro, Brazil), followed by absolute isolation with rubber sheet and metal clamp; then prophylaxis of the selected tooth will be performed with Robson's brush and pumice stone and water, surface washing and drying with cotton balls, removal of carious tissue or affected enamel without dentin support with sharp curettes or low-speed spherical drills. Subsequently, each group will follow the treatment protocols suggested by the manufacturer of restorative materials.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Restorative treatment
Description: For all groups, first the patients will be submitted to the anesthetic technique indicated with Lidocaine + Epinephrine 1: 100,000 (New DFL, Rio de Janeiro, Brazil), followed by absolute isolation with rubber sheet and metal clamp; then prophylaxis of the selected tooth will be performed with Robson's brush and pumice stone and water, surface washing and drying with cotton balls, removal of carious tissue or affected enamel without dentin support with sharp curettes or low-speed spherical drills. Subsequently, each group will follow the treatment protocols suggested by the manufacturer of restorative materials.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Restorative treatment
Description: For all groups, first the patients will be submitted to the anesthetic technique indicated with Lidocaine + Epinephrine 1: 100,000 (New DFL, Rio de Janeiro, Brazil), followed by absolute isolation with rubber sheet and metal clamp; then prophylaxis of the selected tooth will be performed with Robson's brush and pumice stone and water, surface washing and drying with cotton balls, removal of carious tissue or affected enamel without dentin support with sharp curettes or low-speed spherical drills. Subsequently, each group will follow the treatment protocols suggested by the manufacturer of restorative materials.
Study: NCT04986787

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tACS
Description: a non-invasive brain stimulation technique that allows interaction with endogenous cortical oscillatory rhythms

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tACS
Description: a non-invasive brain stimulation technique that allows interaction with endogenous cortical oscillatory rhythms

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tACS
Description: a non-invasive brain stimulation technique that allows interaction with endogenous cortical oscillatory rhythms

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TMS
Description: a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain, it will be specifically cerebellar stimulation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TMS
Description: a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain, it will be specifically cerebellar stimulation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TIS
Description: temporal interference stimulation targeted to striatum, a non-invasive brain stimulation technique that allows interaction with endogenous cortical oscillatory rhythms deep in the brain
Study: NCT05611294

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Topography Guided LASIK Surgery
Description: LASIK surgery, using corneal topography data in treatment profile, to correct myopia or myopia with astigmatism refractive error.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Small Incision Lenticule Extraction Surgery
Description: Corneal lenticule formation using a femtosecond laser, with subsequent lenticule extraction, to correct myopia or myopia with astigmatism refractive error.
Study: NCT05365165

Intervention type: DRUG
Intervention: Sevoflurane
Description: Sevoflurane will be applied during aortic cross- clamping in cardiac surgery
Study: NCT04901039

Intervention type: OTHER
Intervention: Lung ultrasound
Description: Decompensated HF patients will be evaluated at admission and prior to hospital discharge with a range of tools including lung ultrasound imaging

Intervention type: OTHER
Intervention: Echocardiography
Description: Comprehensive echocardiography with evaluation of filling pressures

Intervention type: OTHER
Intervention: Peripheral venous pressure
Description: Assessment of peripheral venous pressure
Study: NCT05330715

Intervention type: OTHER
Group type: OTHER
Intervention: Management
Description: Comparison if different strategies to manage acute emergencies in the pre-hospital setting.

Intervention type: OTHER
Group type: OTHER
Intervention: Management
Description: Comparison if different strategies to manage acute emergencies in the pre-hospital setting.
Study: NCT05563870

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoluminal radiofrequency ablation
Description: Endoluminal Radiofrequency ablation (RFA) of the entire stricture length will be performed using the Habib probe. A current of 7W will be delivered for 90s intervals at a time. If multiple ablation sessions are needed in order to ablate the entire stricture lenght, there will be an overlap of ablated areas in order to ensure proper stricture treatment. Dilation of the stricture prior to RFA delivery will be performed if required. After RFA treatment, biliary drainage of all hepatic territories will be ensured.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic biliary stenting
Description: Endoscopic biliary stenting will be performed via ERCP using multiple plastic stents, in order to ensure propper drainage of all accessed hepatic territories.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic biliary stenting
Description: Endoscopic biliary stenting will be performed via ERCP using multiple plastic stents, in order to ensure propper drainage of all accessed hepatic territories.
Study: NCT06476639

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: High-resolution bilateral groin ultrasound monitoring
Description: Participants in the Interventional Group will undergo surgical excision of the primary tumor, either via radical wide local excision or radical vulvectomy. Post-vulvar surgery, participants will receive a groin node ultrasound every 2 months and a clinical examination every 3 months, for a follow up period of 12 months. Senior imaging specialists review bilateral ultrasound scans for positive lymph nodes or suspicious findings, promptly sending reports to the primary care physician and trial manager if detected within 3 business days. Subsequently, participants consult their primary care physician for options. Depending on clinical judgment, they may be referred for LND or continue with bi-monthly ultrasounds based on preference and clinician guidance.
Study: NCT04901039

Intervention type: OTHER
Intervention: Magnetic resonance imaging
Description: Cardiac magnetic resonance imaging

Intervention type: OTHER
Intervention: Pulmonary scintigraphy
Description: Assessment of pulmonary perfusion with scintigraphy
Study: NCT06548802

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baricitinib
Description: Baricitinib was given 4mg once daily, with the first dose taken within 24 hours of the appearance of lung injury and continued for 14 days.
Study: NCT06046703

Intervention type: OTHER
Intervention: Daily nutritional intake
Description: Nutritional intake with a focus on vitamin B12, but also other micronutrients and macronutrients

Intervention type: OTHER
Intervention: Daily nutritional intake
Description: Nutritional intake with a focus on vitamin B12, but also other micronutrients and macronutrients
Study: NCT04679831

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ujiplus®
Description: Ujiplus® flour, a nutritional supplement will be used to prepare porridge, and each child will be given a serving of 300 ml every school day for 90 days.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Praziquantel 400mg
Description: 400mg of Praziquantel will be given to each child once at the beginning of the study and maize flour porridge fortified only with micronutrients cooked and served to each child, 300 ml per every school day for 90 days,
Study: NCT06269250

Intervention type: OTHER
Intervention: Policy Change
Description: There will be a change with the digitalization in the health care system with the beginning of the year 2024 and between Wave 1 and Wave 2

Intervention type: OTHER
Intervention: Policy Change
Description: There will be a change with the digitalization in the health care system with the beginning of the year 2024 and between Wave 1 and Wave 2
Study: NCT05237895

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Serum Endocan Levels
Description: Detection of Serum Endocan Levels and detection of possible diagnostic association with gestational diabetes

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Serum Endocan Levels
Description: Detection of Serum Endocan Levels and detection of possible diagnostic association with gestational diabetes
Study: NCT05525026

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BTL-785-7
Description: Treatment with the BTL-785-7 applicator to the BTL-785F system.
Study: NCT04830267

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Camrelizumab
Description: Camrelizumab 200mg IV starting day 1 and then every 2 weeks thereafter. Treatment with Camrelizumab will continue until progression or unacceptable toxicity.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: Camrelizumab 200mg IV starting day 1 and then every 2 weeks thereafter. Treatment with Camrelizumab will continue until progression or unacceptable toxicity.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy
Description: Image guided, stereotactic body radiotherapy (27 Gy over 3 fractions given every other day) to a single lesion to start by study day 14 (study day 1 is day of first dose of Camrelizumab).
Study: NCT05137561

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PSMA PET guided prostate biopsy
Description: PSMA PET-guided prostate biopsy from PSMA avid prostatic lesion will be done.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: MRI directed TRUS guided prostate biopsy
Description: TRUS guided MR directed Cognitive fusion prostate biopsy based on the PIRADS scoring
Study: NCT05604599

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intranasal dexmedetomidine
Description: 45 -60 min before the operation, patients will receive dose of dexmedetomidine 1microgram/kg diluted in 10ml 0.9% saline administered to each naris as drops + infusion saline

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous dexmedetomidine
Description: patients will receive loading dose of dexmedetomidine 1 µg/kg diluted in 10ml 0.9% saline infused over 45- 60 min before induction of anesthesia, followed by continuous infusion of (0.4 µ g/kg/h) + intranasal saline.
Study: NCT06253039

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Repeated sprint
Description: * The group will endure four weeks (8 sessions) of the assigned training program in addition to the regular swimming training.~* Data collection sessions: All groups will be evaluated before and after the supervised training period in three testing sessions in normoxia separated by at least 24 hours within 7 days.~* Training sessions: will be performed in the ski ergometer and consist of 4 sets of 5x6s all-out sprints with 24s and 5 min of passive rest between the sprints and sets, respectively.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Repeated sprint
Description: * The group will endure four weeks (8 sessions) of the assigned training program in addition to the regular swimming training.~* Data collection sessions: All groups will be evaluated before and after the supervised training period in three testing sessions in normoxia separated by at least 24 hours within 7 days.~* Training sessions: will be performed in the ski ergometer and consist of 4 sets of 5x6s all-out sprints with 24s and 5 min of passive rest between the sprints and sets, respectively.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Repeated sprint
Description: * The group will endure four weeks (8 sessions) of the assigned training program in addition to the regular swimming training.~* Data collection sessions: All groups will be evaluated before and after the supervised training period in three testing sessions in normoxia separated by at least 24 hours within 7 days.~* Training sessions: will be performed in the ski ergometer and consist of 4 sets of 5x6s all-out sprints with 24s and 5 min of passive rest between the sprints and sets, respectively.
Study: NCT06357650

Intervention type: OTHER
Intervention: No intervention. This is an observational study
Description: This is an observational study. Hence there is no intervention

Intervention type: OTHER
Intervention: No intervention. This is an observational study
Description: This is an observational study. Hence there is no intervention

Intervention type: OTHER
Intervention: No intervention. This is an observational study
Description: This is an observational study. Hence there is no intervention

Intervention type: OTHER
Intervention: No intervention. This is an observational study
Description: This is an observational study. Hence there is no intervention

Intervention type: OTHER
Intervention: No intervention. This is an observational study
Description: This is an observational study. Hence there is no intervention
Study: NCT06050538

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transabdominal preperitoneal (TAPP) using polyprolene mesh
Description: Transabdominal preperitoneal (TAPP) approach for recurrent inguinal hernia using polyprolene mesh

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total extraperitoneal (TEP) hernioplasty using polyprolene mesh
Description: Total extraperitoneal (TEP) approach for recurrent inguinal hernia using polyprolene mesh
Study: NCT06128265

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Extension
Description: Extending time in bed by 2 hours (going to bed earlier and/or waking up later)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Regularity
Description: Consistent bedtimes (within 30min)
Study: NCT05544890

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: All patients will start learning how to activate the transversus abdominal muscle in the first training session. The exercises will be made in 1 to 3 series of among 8 and 15 repetitions and the isometric contractions for 5 to 10 seconds. The rest between series will be of 30 seconds, and between exercise of 2-3 minutes.~Other Names:~- Therapeutic exercise

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: All patients will start learning how to activate the transversus abdominal muscle in the first training session. The exercises will be made in 1 to 3 series of among 8 and 15 repetitions and the isometric contractions for 5 to 10 seconds. The rest between series will be of 30 seconds, and between exercise of 2-3 minutes.~Other Names:~- Therapeutic exercise

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: All patients will start learning how to activate the transversus abdominal muscle in the first training session. The exercises will be made in 1 to 3 series of among 8 and 15 repetitions and the isometric contractions for 5 to 10 seconds. The rest between series will be of 30 seconds, and between exercise of 2-3 minutes.~Other Names:~- Therapeutic exercise

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Manual Therapy
Description: All patients will start learning how to activate the transversus abdominal muscle in the first training session. The exercises will be made in 1 to 3 series of among 8 and 15 repetitions and the isometric contractions for 5 to 10 seconds. The rest between series will be of 30 seconds, and between exercise of 2-3 minutes.~Other Names:~- Manipulation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Kinesiotape
Description: All patients will start learning how to activate the transversus abdominal muscle in the first training session. The exercises will be made in 1 to 3 series of among 8 and 15 repetitions and the isometric contractions for 5 to 10 seconds. The rest between series will be of 30 seconds, and between exercise of 2-3 minutes.~Other Names:~- Kinesiotaping
Study: NCT05197231

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resisted knee extension exercise
Description: Patients in the intervention group will perform a seated knee extension exercise in three sets. Resistance will be adjusted using ankle weights, targeting 8-12 repetitions per set.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV amino acids
Description: IV amino acids (Glavamin, Fresenius Kabi) delivered by continuous infusion at a rate of 0.1 g/kg/h. The infusion is started immediately prior to physiotherapy and continued until all blood samples required for outcome assessment are collected during a 90-minute resting period after the exercise session.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IV amino acids
Description: IV amino acids (Glavamin, Fresenius Kabi) delivered by continuous infusion at a rate of 0.1 g/kg/h. The infusion is started immediately prior to physiotherapy and continued until all blood samples required for outcome assessment are collected during a 90-minute resting period after the exercise session.
Study: NCT06399874

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nightmare Deconstruction and Reprocessing
Description: A psychotherapy that uses exposure to nightmare images for trauma activation in order to facilitate trauma memory reconsolidation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NightWare
Description: Wristband device that detects physiologic signals during sleep that indicate a possible nightmare and gently vibrates to rouse the sleeper without fully waking them.
Study: NCT06549829

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional optimization-led triple prehabilitation Intervention
Description: The nutritional status of the patients was assessed together with the clinical nutritionist to develop an individualized nutritional plan. The experimental group used ordinary dietary supplementation + transoral nutritional supplementation, and the control group used ordinary dietary supplementation. The target energy was basal energy metabolism level \* physical activity level, physical activity level was male: 1.55 female: 1.56; basal energy level was basal metabolism standardized value \* body weight (basal metabolism standardized value for obese patients was 25; basal metabolism standardized value for normal or emaciated patients was 30). Add 600kcal capacity supplement to this. Exercise workouts focused on increasing lung capacity and cardiorespiratory tolerance. Specialized psychological interventions.

Intervention type: OTHER
Group type: OTHER
Intervention: Conventional triple prehabilitation Intervention
Description: Conventional triple prehabilitation: ordinary dietary supplementation; exercise workouts focused on increasing lung capacity and cardiorespiratory tolerance; specialized psychological interventions.
Study: NCT06473909

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CD25 antibody combined glucocorticoid as first-line treatment
Description: CD25 antibody combined glucocorticoid as first-line treatment
Study: NCT04970004

Intervention type: OTHER
Intervention: No intervention
Description: No study intervention will be administered as part of this study.
Study: NCT04928261

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: Patients with early-stage HER2-positive breast cancer who demonstrate a pathological complete response at time of surgery will be treated with HER2 targeted therapy for a total of 9 treatments every 3 weeks (or its equivalent if given weekly) including the treatment received preoperatively.